Nonsteroidal Anti-Inflammatory Drugs and Reversible Female Infertility

Nonsteroidal anti-inflammatory drugs (NSAIDs) are frequently prescribed to women of child-bearing age. Three case series highlight the possibility of a link between NSAIDs and reversible infertility. The pharmacological target of NSAIDs is cyclo-oxygenase (COX), which catalyses the first rate-limiting step in the production of prostaglandins. COX-2, one of two isoenzymes, is active in the ovaries during follicular development. Its inhibition is thought to cause luteinised unruptured follicle (LUF) syndrome, an anovulatory condition characterised by clinical signs of ovulation but in the absence of follicular rupture and ovum release. The evidence linking regular NSAID use to reversible LUF syndrome comes from animal studies and three clinical studies. COX-2—deficient mice have severely compromised ovulation in the presence of apparently normal follicular development. Experimental administration of prostaglandins induced ovulation in rabbits and this was blocked by the administration of indomethacin. The three clinical studies demonstrated the induction of delayed follicular rupture or LUF in previously ovulating women by the administration of NSAIDs. A link can therefore be identified between NSAID use and reversible female infertility and NSAID withdrawal should be considered prior to or concurrent with fertility investigations. Similar content being viewed by others

Rang HP, Dale MM. Pharmacology. London: Churchill Livingstone, 1987 Shaw RW. Treatment of endometriosis. Lancet 1992 Nov; 340(8830): 1267–71 Tsafriri A, Koch Y, Lindner HR. Ovulation rate and serum LH levels in rats treated with indomethacin or PGE2. Prostaglandins 1973 Apr; 3(4): 461–7 Reich R, Kohen F, Naor Z, et al. Possible involvement of lipoxygenase products of arachidonic acid pathway in ovulation. Prostaglandins 1983; 26: 1011–20 Walker RF, Schwartz LW, Manson JM. Ovarian effects of an anti-inflammatory-immunomudulatory drug in the rat. Toxicol Appl Pharmacol 1988 Jun; 94(2): 266–75 Mendonça LLF, Khamashta MA, Nelson-Piercy C. Non-steroidal anti-inflammatory drugs as a possible cause for reversible infertility. Rheumatology 2000 Aug; 39(8): 880–2 Akil M, Amos RS, Stewart P. Infertility may sometimes be associated with NSAID consumption. Br J Rheumatol 1996 Jan; 35(1): 76–8 Smith G, Roberts R, Hall C, et al. Reversible ovulatory failure associated with the development of luteinized unruptured follicles in women with inflammatory arthritis taking nonsteroidal anti-inflammatory drugs. Br J Rheumatol 1996 May; 35(5): 458–62 Kurumbail RG, Stevens AM, Gierse JK, et al. Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents. Nature 1996 Dec; 384: 644–8 Crofford LJ, Lipsky PE, Brooks P, et al. Basic biology and clinical application of specific cyclooxygense-2 inhibitors. Arthritis Rheum 2000 Jan; 43(1): 4–13 Matsumoto H, Ma W, Smalley W, et al. Diversification of cyclooxygenase-2-derived prostaglandins in ovulation and implantation. Biol Reprod 2001 May; 64(5): 1557–65 Bombardier C, Laine L, Reicin A, et al. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis: VIGOR Study Group. N Engl J Med 2000 Nov; 343(21): 1520–8 Silverstein FE, Faich G, Goldstein JL, et al. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: a randomized controlled trial: Celecoxib Long-Term Arthritis Safety Study. JAMA 2000 Sep; 284(10): 1247–55 Perazella MA, Tray K. Selective cyclooxygenase-2 inhibitors: a pattern of nephrotoxicity similar to traditional nonsteroidal anti-inflammatory drugs. Am J Med 2001; 111: 64–7 Reich R, Daphna-Iken D, Chun SY, et al. Preovulatory changes in ovarian expression of collagenases and tissue metalloproteinase inhibitor messenger ribonucleic acid: the role of eicosanoids. Endocrinology 1991 Oct; 129(4): 1869–75 Marik J, Hulka J. Luteinized unruptured follicle syndrome: a subtle cause of infertility. Fertil Steril 1978 Mar; 29(3): 270–4 Jewelewicz R. Management of infertility resulting from ovulation. Am J Obstet Gynecol 1975 Aug; 122(8): 909–20 Liukkonen S, Koskimies AI, Tenhunen A, et al. Diagnosis of luteinized unruptured follicle (LUF) syndrome by ultrasound. Fertil Steril 1984 Jan; 41(1): 26–30 Koninckx PR, De Moor P, Brosens IA. Diagnosis of luteinised unruptured follicle syndrome by steroid hormone assays on peritoneal fluid. Br J Obstet Gynaecol 1980 Nov; 87(11): 929–34 Koninckx PR, Heyns WJ, Corvelyn PA, et al. Delayed onset of luteinisation as a cause of infertility. Fertil Steril 1978 Mar; 29(3): 266–9 Kerin JF, Kirby C, Morris D, et al. Incidence of the luteinized unruptured follicle phenomenon in cycling women. Fertil Steril 1983 Nov; 40(5): 620–6 Hamilton CJCM, Wetzels LCG, Evers JLH, et al. Follicle growth curves and hormonal patterns in patients with the luteinized unruptured follicle syndrome. Fertil Steril 1985 Apr; 43(4): 541–8 Smith WL, De Witt DL. Prostaglandin endoperoxide H synthase-1 and -2. Adv Immunol 1996; 62: 167–215 Lim H, Paria BC, Das SK, et al. Multiple female reproductive failures in cyclooxygenase 2-deficient mice. Cell 1997 Oct; 91: 197–208 Armstrong DT, Grinwich DL, Moon YS, et al. Inhibition of ovulation in rabbits by intrafollicular injection of indomethacin and prostaglandin F2α antiserum. Life Sci 1974 Jan; 14(1): 129–40 Sirois J. Induction of prostaglandin endoperoxide synthase-2 by human chorionic gonadotropin in bovine pre-ovulatory follicles in vitro. Endocrinology 1994 Sep; 135(3): 841–8 Ojeda SR, Campbell WB. An increase in hypothalamic capacity to synthesize prostaglandin E2 precedes the first ovulatory surge of gonadotropins. Endocrinology 1982 Oct; 111(4): 1031–7 Killick S, Elstein M. Pharmacologic production of luteinized unruptured follicles by prostaglandin synthetase inhibitors. Fertil Steril 1987 May; 47(5): 773–7 Athanasiou S, Bourne TH, Khalid A, et al. Effects of indomethacin on follicular structure, vascularity, and function over the periovulatory period in women. Fertil Steril 1996 Mar; 65(3): 556–60 Pall P, Fridén BE, Brännström M. Induction of delayed follicular rupture in the human by the selective COX-2 inhibitor rofecoxib: a randomized double-blind study. Hum Reprod 2001 Jul; 16(7): 1323–8 Mikuni M, Pall M, Peterson PM, et al. The selective prostaglandin endoperoxide synthase-2 inhibitor, NS-398, reduces prostaglandin production and ovulation in vivo and in vitro in the rat. Biol Reprod 1998 Nov; 59(5): 1077–83 Norman RJ. Reproductive consequences of COX-2 inhibition. Lancet 2001 Oct; 358: 1287–8 Nielsen GL, Sørensen HT, Larsen H, et al. Risk of adverse birth outcome and miscarriage in pregnant users of non-steroidal anti-inflammatory drugs: population-based observational study and case-control study. BMJ 2001 Feb; 322(3): 266–70 Chan LY, Yuen PM. Risk of miscarriage in pregnant users of NSAIDs. More information is needed to be able to interpret study’s results. BMJ 2001 Jun; 322: 1365–6 Ericson A, Källén BAJ. Nonsteroidal anti-inflammatory drugs in early pregnancy. Reprod Toxicol 2001 Jul-Aug; 15(4): 371–5 Montenegro MA, Palomino H. Induction of cleft palate in mice by inhibitors of prostaglandin synthesis. J Craniofac Genet Dev Biol 1990; 10(1): 83–94 Chan LY, Chiu PY, Siu SSN, et al. A study of diclofenac-induced teratogenicity during organogenesis using a whole rat embryo culture model. Hum Reprod 2001 Nov; 16(11): 2390–3 Siu SSN, Yeung JHK, Lau TK. A study on placental transfer of diclofenac in first trimester of human pregnancy. Hum Reprod 2000 Nov; 15(11): 2423–25 Janssen NM, Genta MS. The effects of immunosuppressive and anti-inflammatory medications on fertility, pregnancy, and lactation. Arch Intern Med 2000 Mar; 160(5): 610–9

Dr Stone is funded by Tommy’s Campaign. We gratefully acknowledge their continued support. We would also like to thank Professor Peter Braude for his critical review of the manuscript. Author information Authors and Affiliations Corresponding author Rights and permissions About this article Cite this article Stone, S., Khamashta, M.A. & Nelson-Piercy, C. Nonsteroidal Anti-Inflammatory Drugs and Reversible Female Infertility. Drug-Safety 25, 545–551 (2002). https://doi.org/10.2165/00002018-200225080-00001 Published: Issue date: DOI: https://doi.org/10.2165/00002018-200225080-00001